Understanding Ketamine Therapy
Start with the science. Before considering any treatment, it helps to understand what ketamine is, how it differs from conventional medications, and the mechanisms researchers are studying.
How ketamine differs from traditional antidepressants
Most conventional antidepressants - including SSRIs and SNRIs - act primarily on monoamine systems (serotonin, norepinephrine, dopamine) and typically require weeks of daily dosing before any subjective effect appears. Ketamine acts primarily on the glutamate system, the brain's main excitatory neurotransmitter, and is administered in time-limited supervised sessions rather than as a daily medication.
This different mechanism does not make ketamine "better." It makes it different. Each approach has its own evidence base, risks, and appropriate use cases, and the decision between them belongs with a qualified clinician.
Neuroplasticity, glutamate, and NMDA receptors
Ketamine is an NMDA receptor antagonist. NMDA receptors are a subtype of glutamate receptor involved in learning, memory, and synaptic plasticity. By transiently blocking these receptors, ketamine triggers a cascade that researchers believe may increase glutamate signaling on other receptor subtypes and promote short-term synaptic changes.
BDNF and synaptic growth
Animal and early human research suggests ketamine may transiently increase brain-derived neurotrophic factor (BDNF) and markers of synaptic growth in regions implicated in mood regulation. These are mechanistic hypotheses, not proven causes of clinical benefit.
What the evidence supports today
Published evidence is strongest for rapid, time-limited effects on certain depressive symptoms - particularly in treatment-resistant cases - and for acute reduction of suicidal ideation in research settings. Evidence is more limited and still emerging for other conditions. Long-term outcomes, optimal dosing, and durability remain active areas of study.
Continue: Stage 2 - Preparing for treatment. Or read how ketamine works.
Frequently asked questions
Is ketamine the same as an antidepressant?+
No. Ketamine is a dissociative anesthetic studied in research and prescribed off-label in some clinical settings. It acts on different receptor systems than SSRIs and has a different time course of effect.
What is neuroplasticity?+
Neuroplasticity is the brain's capacity to form and reorganize synaptic connections. Research suggests ketamine may temporarily increase markers associated with synaptic growth, but the clinical implications are still being studied.
What does BDNF have to do with this?+
Brain-derived neurotrophic factor (BDNF) supports neuron growth and survival. Some studies suggest ketamine transiently increases BDNF signaling, which is one hypothesized mechanism behind its effects.
Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.